Detalhe da pesquisa
1.
A League of Its Own? Established and Emerging Therapies in Undifferentiated Pleomorphic Sarcoma.
Curr Treat Options Oncol
; 24(3): 212-228, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729198
2.
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Oncologist
; 2022 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35536733
3.
Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma.
Cancer
; 127(23): 4447-4454, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379792
4.
Immune Checkpoint Markers in Superficial Angiosarcomas: PD-L1, PD-1, CD8, LAG-3, and Tumor-Infiltrating Lymphocytes.
Am J Dermatopathol
; 43(8): 556-559, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156018
5.
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial.
Lancet Oncol
; 20(9): 1295-1305, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31351869
6.
Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.
Cancer
; 124(14): 2986-2992, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741773
7.
Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Cancer
; 124(11): 2347-2354, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29579339
8.
Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing.
Oncologist
; 23(2): 179-185, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158372
9.
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies.
Br J Cancer
; 116(12): 1505-1512, 2017 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28463960
10.
A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancer.
Oncologist
; 20(2): 105-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25616430
11.
Can we predict the response to therapy in soft tissue sarcoma?
Future Oncol
; 14(2): 101-104, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29219624
12.
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas.
J Immunother Cancer
; 11(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385724
13.
Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care Therapy.
Otolaryngol Head Neck Surg
; 167(5): 846-851, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35259033
14.
Health Insurance Payer Type and Ethnicity Are Associated with Cancer Clinical Trial Enrollment Among Adolescents and Young Adults.
J Adolesc Young Adult Oncol
; 11(1): 104-110, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34010032
15.
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.
Neuro Oncol
; 24(6): 997-1007, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850167
16.
Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.
JCO Precis Oncol
; 6: e2100424, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35138919
17.
Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration.
Target Oncol
; 16(6): 773-787, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694529
18.
The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
Cancer Med
; 10(10): 3231-3239, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33934525
19.
Novel induction therapy transoral surgery treatment paradigm with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck - Mature clinical and functional outcomes.
Oral Oncol
; 110: 104957, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32823258
20.
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin Contraindication.
Clin Cancer Res
; 26(16): 4260-4267, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32371539